Work

Survival outcomes of patients with relapsed or refractory acute myeloid leukemia after venetoclax combined with hypomethylating agents.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e18808

Authors: Carl Zainaldin, Sankalp Arora, Sri Bathini, Vishruti Pandya, Sejong Bae, Udita Gupta, Sarah Worth`, Kimo Bachiashvili, Ravi Bhatia, Kelly Nicole Godby, Omer Jamy, Sravanti Rangaraju, Barry Diamond, Josh D Oliver, Donna E. Salzman, Antonio Di Stasi, Pankit Vachhani

Institutions: University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281671725

Cites:

Cited by:

Related to: 10